On Wednesday, October 25, the CDC (The Centers for Disease Control and Prevention, decided to produce a new vaccine for shingles, a disease that occurs frequently in seniors. The CDC is a primer public health institute based in Atlanta. This new vaccine called Shingrix, was approved by the FDA (Food and Drug Administration) a few days before the CDC decision was made. Shingrix was given recommendation over the only Shingles vaccine on the market over a decade, Zotavax. Insurance companies have agreed to cover the cost of Shingrix which the maker, GlaxoSmithKline, estimates to be $280 for 2 doses. Data from the CDC shows that almost ⅓ of all people will acquire shingles. Shingles, also known as herpes zoster, is caused by the varicella-zoster
